Related Experiment Video
Updated: Aug 9, 2026

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Controlled Decompression Alleviates Motor Dysfunction by Regulating Microglial Polarization via the HIF-1α Signaling
Jie Zheng1, Chenxu Zhang1, Yonghui Wu1
1Department of Neurosurgery, The 904th Hospital of PLA, Wuxi Clinical College of Anhui Medical University, Wuxi, 214044, Jiangsu, China.
Insights
Controlled decompression (CDC) reduces inflammation and neuronal death after traumatic intracranial hypertension (TIH) by shifting microglia to an anti-inflammatory M2 state, unlike rapid decompression (RDC). This mechanism involves regulating hypoxia-inducible factor-1α (HIF-1α).
Area of Science:
- Neuroscience
- Surgical Research
- Inflammation Biology
Background:
- Decompressive craniectomy (DC) is crucial for managing intracranial hypertension (IH) after severe traumatic brain injury (sTBI) and stroke.
- Controlled decompression (CDC) shows promise over rapid decompression (RDC) in improving outcomes, but underlying mechanisms require elucidation.
- Inflammation and microglial polarization are key factors in brain injury progression following IH.
Purpose of the Study:
- To investigate the effects of CDC on regulating inflammation in a rat model of traumatic intracranial hypertension (TIH).
- To identify the specific molecular mechanisms, particularly involving hypoxia-inducible factor-1α (HIF-1α), by which CDC exerts its protective effects.
- To compare the impact of CDC versus RDC on microglial polarization and cytokine release.
Main Methods:
- Established a rat model of TIH using epidural balloon pressurization.
- Administered CDC and RDC, assessing motor function, neuronal death, and inflammatory markers.
- Analyzed microglial polarization (M1 vs. M2 phenotypes) and cytokine profiles.
- Investigated the role of HIF-1α using specific inhibitors (2-methoxyestradiol, 2-ME2) and agonists (dimethyloxaloylglycine, DMOG).
Main Results:
- CDC significantly alleviated motor dysfunction and neuronal death compared to RDC.
- RDC promoted pro-inflammatory M1 microglia polarization and cytokine release, while CDC induced anti-inflammatory M2 polarization and cytokine release.
- CDC reduced HIF-1α expression, and manipulating HIF-1α levels (via 2-ME2 or DMOG) confirmed its role in mediating CDC's anti-inflammatory and neuroprotective effects.
- CDC ameliorated cerebral hypoxia and reduced HIF-1α expression.
Conclusions:
- Controlled decompression (CDC) effectively mitigates inflammation, neuronal death, and motor deficits in a rat model of traumatic intracranial hypertension (TIH).
- The protective mechanisms of CDC involve the regulation of HIF-1α-mediated microglial phenotype polarization towards an anti-inflammatory M2 state.
- These findings enhance understanding of CDC's benefits and support further clinical research into HIF-1α targeted therapies for IH.
Abstract:
Decompressive craniectomy (DC) is a major form of surgery that is used to reduce intracranial hypertension (IH), the most frequent cause of death and disability following severe traumatic brain injury (sTBI) and stroke. Our previous research showed that controlled decompression (CDC) was more effective than rapid decompression (RDC) with regard to reducing the incidence of complications and improving outcomes after sTBI; however, the specific mechanisms involved have yet to be elucidated. In the present study, we investigated the effects of CDC in regulating inflammation after IH and attempted to identify the mechanisms involved. Analysis showed that CDC was more effective than RDC in alleviating motor dysfunction and neuronal death in a rat model of traumatic intracranial hypertension (TIH) created by epidural balloon pressurization. Moreover, RDC induced M1 microglia polarization and the release of pro-inflammatory cytokines. However, CDC treatment resulted in microglia primarily polarizing into the M2 phenotype and induced the significant release of anti-inflammatory cytokines. Mechanistically, the establishment of the TIH model led to the increased expression of hypoxia-inducible factor-1α (HIF-1α); CDC ameliorated cerebral hypoxia and reduced the expression of HIF-1α. In addition, 2-methoxyestradiol (2-ME2), a specific inhibitor of HIF-1α, significantly attenuated RDC-induced inflammation and improved motor function by promoting M1 to M2 phenotype transformation in microglial and enhancing the release of anti-inflammatory cytokines. However, dimethyloxaloylglycine (DMOG), an agonist of HIF-1α, abrogated the protective effects of CDC treatment by suppressing M2 microglia polarization and the release of anti-inflammatory cytokines. Collectively, our results indicated that CDC effectively alleviated IH-induced inflammation, neuronal death, and motor dysfunction by regulating HIF-1α-mediated microglial phenotype polarization. Our findings provide a better understanding of the mechanisms that underlie the protective effects of CDC and promote clinical translational research for HIF-1α in IH.
More Related Videos
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

